Perform Another (Advanced) Search

1.  Study Posting (1570) Trial #156486, Coronary Artery Disease, Morristown, NJ
...Patient presenting with triple vessel disease. Patient Exclusion Criteria: • ST elevation M.I. • Pre procedure cardiac arrest within 24 hours. • Subject in cardiogenic shock Kelly Colucci, Manager, Grants and Contracts Atlantic Health ...
View Page

2.  Study Posting (2348) Trial #109113, Erectile Dysfunction, New York, NY
...mg. 3. Has an unstable angina within 6 months, or has a history of sudden cardiac arrest, myocardial infarction or heart bypass surgery within the past 90 days. 4. Has a history ...
View Page

3.  Study Posting (2348) Trial #89023, Prostate Cancer, New York, NY
...medicines). d. Has an unstable angina within 6 months, or has a history of sudden cardiac arrest or heart bypass surgery within the past 90 days. e. Has a history of uncontrolled ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (55), Diabetes Mellitus Types I and II
...with diabetes, AGI-1067 showed a 22% reduction in hard cardiovascular events of cardiovascular death, cardiac arrest, myocardial infarction and stroke (p=0.062). Additional phase III trials are currently underway. August ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (213), Heart Disease
...with diabetes, AGI-1067 showed a 22% reduction in hard cardiovascular events of cardiovascular death, cardiac arrest, myocardial infarction and stroke (p=0.062). Additional phase III trials are currently underway. March ...
View Page

6.  Newly Approved Drug Therapies (999) Cleviprex (clevidipine), The Medicines Company,
...severe or essential hypertension may include, but are not limited to, the following: • Myocardial infarction • Cardiac arrest • Syncope • Dyspnea Mechanism of Action Cleviprex is an intravenous short acting dihydropyridine calcium channel antagonist ...
View Page

7.  Newly Approved Drug Therapies (624) Argatroban Injection, Texas Biotechnology Corporation, SmithKline Beecham,
...the historical control group. Side Effects Side effects may include: • Dyspnea • Hypotension • Fever • Diarrhea • Sepsis • Cardiac Arrest • Nausea • Ventricular tachycardia • Pain • Urinary tract infection • Vomiting • Infection • Pneumonia • Atrial fibrillation • Coughing • Abnormal renal ...
View Page

8.  Newly Approved Drug Therapies (895) Myozyme (alglucosidase alfa), Genzyme,
...has been associated with cardiac arrhythmia, including ventricular fibrillation, ventricular tachycardia and bradycardia, resulting in cardiac arrest or death, or requiring cardiac resuscitation or defibrillation. Appropriate caution and support measures should be ...
View Page

9. Clinical Trial Results by Drug Names
...or sudden unexpected death within 24 hrs of a definite or probable cardiac event (syncope, cardiac arrest, chest pain, infarction, arrhythmia, etc.) without documented etiology. All primary cardiac endpoints occurred during the ...
View Page

10. Clinical Trial Results by Drug Names
...experienced headache and hypersensitivity, respectively, and 3 patients in the epoetin group experienced intestinal ischemia, cardiac arrest, and subdural hematoma, respectively. Among the patients who died in the study (4% in the ...
View Page

11. Clinical Trial Results by Drug Names
...group, and 17 (8%) in the epoetin group. The most common causes of death were cardiac arrest and chronic renal failure. Among the patients who died in the study baseline risk factors ...
View Page